*Ukraine says' Easter truce' is over. LONDON, April 23- Brent crude oil edged higher above $109 a barrel on Wednesday after stronger-than-expected economic data from China and Europe reinforced the outlook for global demand growth, and as the unfolding crisis in Ukraine deterred sellers.» Read More
U.S. equity funds are reporting $19 billion worth of inflows this week. Mark Teed, Teed Capital Management, weighs in.
What to expect in tomorrow's trading session, with Cliff Davis, BNP Paribas; Robert Luna, SureVest Capital Management; and Laif Meidell, American Wealth Management.
Alcoa CEO Klaus Kleinfeld discusses quarterly earnings, and his expectations for markets and business in 2013.
CNBC's John Harwood reports the latest on the U.S. debt; and discussing whether the debt ceiling fight will damage the economy, with CNBC's Steve Liesman and Lindsey Piegza, FTN financial economist.
CNBC's Maria Bartiromo reports Alcoa's Q4 earnings.
The market is closing lower for a second day as earnings season kicks off with Alcoa reporting in a few moments, with Mark Newton, Greywolf Execution Partners; David Sowerby, Loomis Sayles; and Scott Wren, Wells Fargo Advisors.
Alcoa is set to kick off Q4's earnings season, and discussing how important its announcement to the market is, Ben Willis, Albert Fried & Co.
CNBC's Jeff Cox offers insight on a trend he sees in the markets that says there will be more days in the red in the immediate future. Richard Bernstein, Richard Bernstein Advisors CEO, weighs in.
Bob Doll, Nuveen Asset Management, explains why he thinks 2013 will be a winning year for the markets.
Harry Dent of HS Dent Investment Management explains why he predicts a market crash in the third quarter of the year and that the U.S. is headed towards bankruptcy. Ed Butowsky, Chapwood Investments; Carol Roth, author of "The Entrepreneur Equation"; and CNBC's Rick Santelli, weigh in.
CNBC's Sharon Epperson and American Petroleum Institute CEO Jack Gerard discuss plans for the Keystone XL Pipeline.
The iShare Biotech ETF is up 32 percent over the past year. Jean-Jacques Bienaime, BioMarin Pharmaceutical CEO, discusses the reason behind his company behind up 24.9 percent in the last 3 months.
Discussing opportunities in the market, with Andrew Slimmon, Morgan Stanley Wealth Management.
Onyx Pharmaceuticals CEO Dr. Anthony Coles discusses his company's thyroid cancer drug and its blood cancer drug and its partnership with Bayer.
CNBC's Rick Santelli reports on the government's $32 billion auction today of 3-year notes.
Google tracks searches for flu-related terms, and overall flu searches are up 200 percent from the 3-year average, reports CNBC's Bertha Coombs.
Earnings season kicks off today with Alcoa reporting after the bell, and what the Street is focusing on, with Kenny Polcari of O'Neil Securities director.
Taking a closer look at what Google's chart looks like now, with Carter Worth, Oppenheimer and John Stephenson, First Asset Investment Management.
Nicholas Brooks, head of research and investment strategy at ETF Securities, shares his outlook on commodity ETFs like Physical Swiss Gold.
More than 250 retail and apparel titans are gathering at the Women's Wear Daily Apparel & Retail CEO Summit at New York City's Plaza Hotel. CNBC's Courtney Reagan reports.